Singapore markets close in 7 hours 51 minutes
Straits Times Index
3,322.08 -8.69 (-0.26%) Nikkei
39,322.52 +284.36 (+0.73%) Hang Seng
18,366.95 -109.85 (-0.59%) FTSE 100
8,228.48 -16.89 (-0.20%) Bitcoin USD
69,386.48 -156.26 (-0.22%) CMC Crypto 200
1,438.93 -7.74 (-0.54%)
PFE Dec 2024 33.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:24AM EDT. Market open.
| Previous close | 0.6700 |
| Open | 0.4600 |
| Bid | 0.4200 |
| Ask | 0.6100 |
| Strike | 33.00 |
| Expiry date | 2024-12-20 |
| Day's range | 0.4600 - 0.5600 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.23k |
ZacksModerna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
ZacksPfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksGSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
GSK's Arexvy becomes the first RSV vaccine approved for adults aged 50-59 who are at high risk.
© 2024 Yahoo. All rights reserved.